December 09, 2011
FDA Wants More Risk Information On Labeling
Health officials are requesting that birth control pills, including the widely used Yaz and Yasmin, update the risk information to include recent data suggesting a higher risk of blood clots with use of the drug. The FDA panel of experts voted 21-5 that labeling made by Bayer is inadequate. A recent study by the FDA found women taking Yasmin had a 75% greater chance of suffering a blood clot than patients taking a combination of other drugs.